Abstract
Polyamine metabolism and its significance in diseases characterized by rapid cell proliferation have been reviewed recently.1, 2 These reviews emphasize the importance of the polyamine biosynthetic pathway as a promising target for the design of new therapeutic agents and summarize the progress made in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.E. Pegg, Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy, Cancer Res. 48: 759 (1988).
P.P. McCann, A.E. Pegg, and A. Sjoerdsma, “Inhibition of Polyamine Metabolism, Biological Significance and Basis for New Therapies”, Academic Press Inc., Orlando (1987).
N. Seiler, Functions of polyamine acetylation, Can. J. Physiol.Pharmacol. 65: 2024 (1987).
C.J. Bacchi, and P.P. McCann, Parasitic protozoa and polyamines, in: “Inhibition of Polyamine Metabolism, Biological Significance and Basis for New Therapies”, P.P. McCann, A.E. Pegg, and A. Sjoerdsma, eds., Academic Press Inc., Orlando, pp. 317–344 (1987).
P.S. Sunkara, and S.B. Baylin, Inhibitors of polyamine biosynthesis: cellular and in vivo effects on tumor proliferation, in: “Inhibition of Polyamine Metabolism, Biological Significance and Basis of New Therapies”, P.P. McCann, A.E. Pegg, and A. Sjoerdsma, eds., Academic Press Inc., Orlando, pp. 121–140 (1987).
J. Bartholeyns, P. Mamont, and P. Casara, Antitumor properties of (2R, 5R)-6-heptyne-2.5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase in rodents, Cancer Res. 44: 4972 (1984).
N. Claverie, J.-L. Pasquali, P.S. Mamont, C. Danzin, M. Weil-Bousson, and M. Siat, Immunosuppressive effects of (2R, 5R)-6-heptyne-2, 5-diamine, and inhibitor of polyamine synthesis. II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice, Clin. Exp. Immunol. 72: 293 (1988).
P.J. Schechter, J.L.R. Barlow, and A. Sjoerdsma, Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases, in: “Inhibition of Polyamine Metabolism, Biological Significance and Basis of New Therapies”, P.P. McCann, A.E. Pegg, and A. Sjoerdsma, eds., Academic Press Inc., Orlando, pp. 345–364 (1987).
P.S. Mamont, M.-C. Duchesne, A.-M. Joder-Ohlenbusch, and J. Grove, Effects of ornithine decarboxylase inhibitors on cultured cells, in: “Enzyme-Activated Irreversible Inhibitors”, N. Seiler, M.J. Jung, and J. Koch-Weser eds., Elsevier/North Holland Biochemical Press, Amsterdam, pp. 43–54 (1978).
C. Danzin, P. Casara, N. Claverie, B.W. Metcalf, and M.J. Jung, (2R, 5R)-6-heptyne-2, 5-diamine, an extremely potent inhibitor of mammalian ornithine decarboxylase, Biochem. Biophys. Res. Commun. 116: 237 (1983).
P.S. Mamont, M. Siat, A.-M. Joder-Ohlenbusch, A. Bernhardt, and P. Casara, Effects of [2R, 5R]-6-heptyne-2, 5-diamine, a potent inhibitor of L-ornithine decarboxylase, on rat hepatoma cells cultured in vitro. Eur. J. Biochem. 142: 457 (1984).
P. Bey, F. Gerhart, V. Van Dorsselaer, and C. Danzin, α-(fluoro-methyl) dehydroornithine and α-(fluoromethyl) dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase, J. Med. Chem. 26: 1551 (1983).
P.S. Mamont, C. Danzin, M. Kolb, F. Gerhart, P. Bey, and A. Sjoerdsma, Narked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl) dehydroornithine, Biochem. Pharmacol. 35: 159 (1986).
A.E. Pegg and D.B. Jones, J.A. Secrits III, Effects of inhibitors of S-adenosylmethionine decarboxylase on polyamine content and growth of L1210 cells, Biochem. 27: 1408 (1988).
D.M. Pett, and H.S. Ginsberg, Metabolism of polyamines in KB cells, Fed. Proc. 27: 615 (1968).
J.E. Kay, and V.J. Lindsay, Control of ornithine decarboxylase activity in stimulated human lymphocytes by putrescine and spermidine, Biochem. J. 132: 791 (1973).
J. Jänne, H. Pösö, and A. Raina, Polyamines in rapid growth and cancer, Biochem. Biophys. Acta 473: 241 (1978).
O. Heby, and J. Jänne, Polyamine antimetabolites: Biochemistry, specificity, and biological effects of inhibitors of polyanine synthesis, in.: “Polyamines in Biology and Medicine”, D.R. Morris, and L.J. Marton, eds., Marcel Dekker, New York, pp. 243–310, (1981).
P.S. Mamont, A.-M. Joder-Ohlenbusch, M. Nussli, and J. Grove, Indirect evidence for a strict negative control of S-adenosyl-L-methionine decarboxylase by spermidine in rat hepatoma cells, Biochem. J. 196: 411 (1981).
C.W. Porter, B. Ganis, T. Vinson, L.J. Marton, D.L. Kramer, and R. Bergeron, Comparison and characterization of growth inhibition in L1210 cells by α-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1, N8-Bis(ethyl)spermidine, an apparent regulator of the enzyme, Cancer Res. 46: 6279 (1986).
C.W. Porter, J. McManis, R.A. Casero, and R. Bergeron, Relative abilities of bis (ethyl) derivatives of putrescine, spermidine and spermine to regulate polyarnine biosynthesis and inhibit L1210 leukemia cell growth, Cancer Res. 47: 2821 (1987).
J.C. Baillon, P.S. Mamont, J. Wagner, F. Gerhart, and P. Lux, Fluorinated analogues of spermidine as substrates of spermine synthase, Eur. J. Biochem., in press.
R.D. Chambers, The influence of fluorine or fluorocarbon groups on some reaction centres, in.: “Fluorine Organic Chemistry”, R.D. Chambers, ed., John Wiley and Sons, New York, pp. 64–96, (1973).
A.E. Pegg, Recent advances in the biochemistry of polyamines in eu-karyotes, Biochem. J., 234: 249 (1986).
L. Persson, I. Holm, and O. Heby, Regulation of ornithine decarboxylase mRNA translation by polyamines, J. Biol. Chem. 263: 3528 (1988).
T. Karaeji, and A.E. Pegg, Inhibition of translation of mRNAs for ornithine decarboxylase and S-adenosyl methionine decarboxylase by polyamines, J. Biol. Chem. 262: 2427 (1987).
A.E. Pegg, and J.K. Coward, Growth of mammalian cells in the absence of the accumulation of spermine. Biochem. Biophys. Res. Commun. 133: 82 (1985).
S. Sarhan, B. Knödgen, F. Gerhart, and N. Seiler, Chain-fluorinated polyamines as tumor markers. I. In vivo transformation of 2, 2-di-fluoroputrescine into 6, 6-difluorospermidine and 6, 6-difluoro-spermine, Int. J. Biochem. 19: 843 (1987).
F. Dezeure, S. Sarhan, and N. Seiler, Chain-fluorinated polyamines as tumor markers. IV. Comparison of 2-fluoroputrescine and 2, 2-difluoroputrescine as substrates of spermine synthase in vitro and in vivo, Int. J. Biochem., submitted for publication.
W.E. Hull, W. Kuntz, R.E. Port, and N. Seiler, Chain-fluorinated polyamines as tumor markers. III. Determination of geminal difluoropolyamines and their precursor 2, 2-difluoroputrescine in normal tissues and experimental tumors by in vitro and in vivo 19F-NMR spectroscopy, NMR in Biomed., in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Mamont, P.S., Claverie, N., Gerhart, F. (1988). Fluorine-Containing Polyamines: Biochemistry and Potential Applications. In: Zappia, V., Pegg, A.E. (eds) Progress in Polyamine Research. Advances in Experimental Medicine and Biology, vol 250. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5637-0_61
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5637-0_61
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5639-4
Online ISBN: 978-1-4684-5637-0
eBook Packages: Springer Book Archive